SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum (Q44497270)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2003

Language	Label	Description	Also known as
English	SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum	scientific article published in July 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

1

object named as

Jadwiga Wardas

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Marta Dziedzicka-Wasylewska

3

object named as

Marta Dziedzicka-Wasylewska

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Małgorzata Pietraszek

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

977

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

270-277

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Metabolic mapping of rat striatum: somatotopic organization of sensorimotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Molecular effects of dopamine on striatal-projection pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Zona incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: differences between dorsal and ventral striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

The role of striatal adenosine A2A receptors in regulation of the muscle tone in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902759-8

7 January 2021

Identifiers

10.1016/S0006-8993(03)02759-8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44497270&oldid=2025736490"